Strum Jay 4
4 · G1 Therapeutics, Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Strum Jay
Chief Scientific Officer
Transactions
- Award
Stock Options (Right to Buy)
2018-01-02+25,000→ 25,000 totalExercise: $20.49Exp: 2028-01-02→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on January 02, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.